Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Love Insider Profile
4 Followers
William Love, Chief Scientific Officer, Ten Percent Owner at Destiny Pharma plc, holds 6.51M shares in Destiny Pharma plc (Ticker: GB:DEST). Most recently, William Love Sold 350,000p shares of Destiny Pharma plc on Jun 11, 2021 for an estimated value of 420.00K.
William Love has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Scientific Officer, Ten Percent Owner
Roles that William Love holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by William Love
William Love's Trading History
List of latest transactions for each holding click on a transaction to see William Love's performance on stock
You May Also Like
William Love insider profile FAQ
What is the percentage of profitable transactions made by William Love?
The percentage of profitable transactions made by William Love is ―.
What is the average return per transaction made by William Love?
The average return per transaction made by William Love is ―.
What stocks does William Love hold?
William Love holds: GB:DEST stocks.
What was William Love’s latest transaction?
William Love latest transaction was an Informative Sell of 420.00K.
What was William Love's most profitable transaction?
William Love’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is William Love's role in Destiny Pharma plc?
William Love's role in Destiny Pharma plc is Chief Scientific Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.